Literature DB >> 18775890

Staphylococcus hominis subsp. novobiosepticus strains causing nosocomial bloodstream infection in Brazil.

Izabel Cristina Vanzato Palazzo1, Pedro A d'Azevedo, Carina Secchi, Antonio Carlos C Pignatari, Ana Lúcia da Costa Darini.   

Abstract

OBJECTIVES: To report the isolation of six Staphylococcus hominis subsp. novobiosepticus (SHN) strains from hospitalized patients with bloodstream infections in two Brazilian hospitals and to characterize their susceptibility profile to several antimicrobials.
METHODS: Species identification was performed by biochemical methods and sodA gene sequencing. The MICs of antimicrobials were determined by broth and agar dilution methods and by Etest. Isolates were typed by PFGE and PCR amplification was used to detect the ccr gene complex and the mec class. Morphometric evaluation of cell wall was performed by transmission electron microscopy (TEM).
RESULTS: Susceptibility profiles indicated that the majority of isolates (five) were multidrug-resistant. Overlapping and multiplex PCR showed that five out of the six strains harboured SCCmec type III with class A mec and type 3 ccr. The initial vancomycin MIC value of 4 mg/L for these strains increased to 16-32 mg/L after growth for 10 days in BHI broth supplemented with this antimicrobial. TEM indicated that vancomycin resistance was associated with cell wall thickening and to another mechanism not fully elucidated. Only one SHN strain was oxacillin- and vancomycin-susceptible. The nosocomial infections in at least five of the patients from both hospitals were caused by a single clone of SHN.
CONCLUSIONS: It is very important to consider SHN strains as the cause of nosocomial infections. The clinical implications resulting from the pattern of multidrug resistance in these strains may be complicated by the emergence of vancomycin resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775890     DOI: 10.1093/jac/dkn375

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

Review 1.  Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus.

Authors:  M Widerström; J Wiström; A Sjöstedt; T Monsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

2.  Comparison of the etiological relevance of Staphylococcus haemolyticus and Staphylococcus hominis.

Authors:  Hagen Frickmann; Andreas Hahn; Romy Skusa; Nils Mund; Vivian Viehweger; Thomas Köller; Kerstin Köller; Norbert Georg Schwarz; Karsten Becker; Philipp Warnke; Andreas Podbielski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-19       Impact factor: 3.267

3.  Staphylococcus hominis subsp. novobiosepticus, an emerging multidrug-resistant bacterium, as a causative agent of septicaemia in cancer patients.

Authors:  Nishat Hussain Ahmed; Frincy K Baruah; Rajesh K Grover
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

4.  Vancomycin-resistant Staphylococcus hominis endophthalmitis following cataract surgery.

Authors:  Jun Yeon Won; Moosang Kim
Journal:  Clin Ophthalmol       Date:  2013-06-17

5.  Multilocus sequence typing and further genetic characterization of the enigmatic pathogen, Staphylococcus hominis.

Authors:  Liangfen Zhang; Jonathan C Thomas; Maria Miragaia; Ons Bouchami; Fernando Chaves; Pedro A d'Azevedo; David M Aanensen; Herminia de Lencastre; Barry M Gray; D Ashley Robinson
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

6.  Microbiological and molecular characterization of Staphylococcus hominis isolates from blood.

Authors:  Soraya Mendoza-Olazarán; Rayo Morfin-Otero; Eduardo Rodríguez-Noriega; Jorge Llaca-Díaz; Samantha Flores-Treviño; Gloria Ma González-González; Licet Villarreal-Treviño; Elvira Garza-González
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

7.  Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus hominis strains isolated from clinical specimens.

Authors:  Ewa Szczuka; Nicoletta Makowska; Karolina Bosacka; Anna Słotwińska; Adam Kaznowski
Journal:  Folia Microbiol (Praha)       Date:  2015-08-09       Impact factor: 2.099

8.  Antibiotic Susceptibility of Biofilm Cells and Molecular Characterisation of Staphylococcus hominis Isolates from Blood.

Authors:  Soraya Mendoza-Olazarán; Rayo Morfín-Otero; Licet Villarreal-Treviño; Eduardo Rodríguez-Noriega; Jorge Llaca-Díaz; Adrián Camacho-Ortiz; Gloria M González; Néstor Casillas-Vega; Elvira Garza-González
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.